This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Tel Aviv University. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2014
Title: Avraham Weizman: Innovator in Psychotropic Agents
Introduction
Avraham Weizman is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of psychotropic agents, particularly those targeting glutamate NMDA activity. With a total of 2 patents, his work focuses on developing novel compounds for the treatment of psychological and psychiatric disorders.
Latest Patents
Weizman's latest patents include innovative compounds and pharmaceutical compositions aimed at addressing psychological and psychiatric diseases. His inventions provide new avenues for treatment, showcasing the potential of glutamate NMDA activity in psychotropic agents.
Career Highlights
Throughout his career, Avraham Weizman has been associated with prominent institutions such as Ramot at Tel Aviv University Ltd. and Bar-Ilan University. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Weizman has collaborated with esteemed colleagues, including Moshe Portnoy and Irit Gil-Ad. These partnerships have enriched his research and fostered innovation in the field of psychotropic agents.
Conclusion
Avraham Weizman stands out as an influential inventor in the realm of psychotropic agents, with a focus on glutamate NMDA activity. His contributions are paving the way for new treatments in mental health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile